 | • レポートコード：MRC2-11QY06859 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はグルコシルセラミダーゼのグローバル市場について調査・分析したレポートです。種類別（AVRRD-02、LTI-291、NCGC-607、Pcgin、その他）市場規模、用途別（遺伝性疾患、ゴーシェ病、パーキンソン病、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別グルコシルセラミダーゼの競争状況、市場シェア ・世界のグルコシルセラミダーゼ市場：種類別市場規模 2015年-2020年（AVRRD-02、LTI-291、NCGC-607、Pcgin、その他） ・世界のグルコシルセラミダーゼ市場：種類別市場規模予測 2021年-2026年（AVRRD-02、LTI-291、NCGC-607、Pcgin、その他） ・世界のグルコシルセラミダーゼ市場：用途別市場規模 2015年-2020年（遺伝性疾患、ゴーシェ病、パーキンソン病、その他） ・世界のグルコシルセラミダーゼ市場：用途別市場規模予測 2021年-2026年（遺伝性疾患、ゴーシェ病、パーキンソン病、その他） ・北米のグルコシルセラミダーゼ市場分析：米国、カナダ ・ヨーロッパのグルコシルセラミダーゼ市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのグルコシルセラミダーゼ市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のグルコシルセラミダーゼ市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのグルコシルセラミダーゼ市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Amicus Therapeutics, Inc.、Bioorganic Research and Services S.A.、greenovation Biotech GmbH、JCR Pharmaceuticals Co., Ltd.、Pharming Group N.V.、Protalix BioTherapeutics, Inc.、Takeda、The International Biotechnology Center (IBC) Generium ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Glucosylceramidase Market
The global Glucosylceramidase market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Glucosylceramidase Scope and Market Size
Glucosylceramidase market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Glucosylceramidase market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Glucosylceramidase market is segmented into
AVRRD-02
LTI-291
NCGC-607
Pcgin
Others
Segment by Application, the Glucosylceramidase market is segmented into
Genetic Disorders
Gaucher Disease
Parkinson’s Disease
Others
Regional and Country-level Analysis
The Glucosylceramidase market is analysed and market size information is provided by regions (countries).
The key regions covered in the Glucosylceramidase market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Glucosylceramidase Market Share Analysis
Glucosylceramidase market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Glucosylceramidase business, the date to enter into the Glucosylceramidase market, Glucosylceramidase product introduction, recent developments, etc.
The major vendors covered:
Amicus Therapeutics, Inc.
Bioorganic Research and Services S.A.
greenovation Biotech GmbH
JCR Pharmaceuticals Co., Ltd.
Pharming Group N.V.
Protalix BioTherapeutics, Inc.
Takeda
The International Biotechnology Center (IBC) Generium
1 Study Coverage
1.1 Glucosylceramidase Product Introduction
1.2 Market Segments
1.3 Key Glucosylceramidase Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Glucosylceramidase Market Size Growth Rate by Type
1.4.2 AVRRD-02
1.4.3 LTI-291
1.4.4 NCGC-607
1.4.5 Pcgin
1.4.6 Others
1.5 Market by Application
1.5.1 Global Glucosylceramidase Market Size Growth Rate by Application
1.5.2 Genetic Disorders
1.5.3 Gaucher Disease
1.5.4 Parkinson’s Disease
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Glucosylceramidase Market Size, Estimates and Forecasts
2.1.1 Global Glucosylceramidase Revenue 2015-2026
2.1.2 Global Glucosylceramidase Sales 2015-2026
2.2 Global Glucosylceramidase, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Glucosylceramidase Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Glucosylceramidase Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Glucosylceramidase Competitor Landscape by Players
3.1 Glucosylceramidase Sales by Manufacturers
3.1.1 Glucosylceramidase Sales by Manufacturers (2015-2020)
3.1.2 Glucosylceramidase Sales Market Share by Manufacturers (2015-2020)
3.2 Glucosylceramidase Revenue by Manufacturers
3.2.1 Glucosylceramidase Revenue by Manufacturers (2015-2020)
3.2.2 Glucosylceramidase Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Glucosylceramidase Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Glucosylceramidase Revenue in 2019
3.2.5 Global Glucosylceramidase Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Glucosylceramidase Price by Manufacturers
3.4 Glucosylceramidase Manufacturing Base Distribution, Product Types
3.4.1 Glucosylceramidase Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Glucosylceramidase Product Type
3.4.3 Date of International Manufacturers Enter into Glucosylceramidase Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Glucosylceramidase Market Size by Type (2015-2020)
4.1.1 Global Glucosylceramidase Sales by Type (2015-2020)
4.1.2 Global Glucosylceramidase Revenue by Type (2015-2020)
4.1.3 Glucosylceramidase Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Glucosylceramidase Market Size Forecast by Type (2021-2026)
4.2.1 Global Glucosylceramidase Sales Forecast by Type (2021-2026)
4.2.2 Global Glucosylceramidase Revenue Forecast by Type (2021-2026)
4.2.3 Glucosylceramidase Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Glucosylceramidase Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Glucosylceramidase Market Size by Application (2015-2020)
5.1.1 Global Glucosylceramidase Sales by Application (2015-2020)
5.1.2 Global Glucosylceramidase Revenue by Application (2015-2020)
5.1.3 Glucosylceramidase Price by Application (2015-2020)
5.2 Glucosylceramidase Market Size Forecast by Application (2021-2026)
5.2.1 Global Glucosylceramidase Sales Forecast by Application (2021-2026)
5.2.2 Global Glucosylceramidase Revenue Forecast by Application (2021-2026)
5.2.3 Global Glucosylceramidase Price Forecast by Application (2021-2026)
6 North America
6.1 North America Glucosylceramidase by Country
6.1.1 North America Glucosylceramidase Sales by Country
6.1.2 North America Glucosylceramidase Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Glucosylceramidase Market Facts & Figures by Type
6.3 North America Glucosylceramidase Market Facts & Figures by Application
7 Europe
7.1 Europe Glucosylceramidase by Country
7.1.1 Europe Glucosylceramidase Sales by Country
7.1.2 Europe Glucosylceramidase Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Glucosylceramidase Market Facts & Figures by Type
7.3 Europe Glucosylceramidase Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Glucosylceramidase by Region
8.1.1 Asia Pacific Glucosylceramidase Sales by Region
8.1.2 Asia Pacific Glucosylceramidase Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Glucosylceramidase Market Facts & Figures by Type
8.3 Asia Pacific Glucosylceramidase Market Facts & Figures by Application
9 Latin America
9.1 Latin America Glucosylceramidase by Country
9.1.1 Latin America Glucosylceramidase Sales by Country
9.1.2 Latin America Glucosylceramidase Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Glucosylceramidase Market Facts & Figures by Type
9.3 Central & South America Glucosylceramidase Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Glucosylceramidase by Country
10.1.1 Middle East and Africa Glucosylceramidase Sales by Country
10.1.2 Middle East and Africa Glucosylceramidase Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Glucosylceramidase Market Facts & Figures by Type
10.3 Middle East and Africa Glucosylceramidase Market Facts & Figures by Application
11 Company Profiles
11.1 Amicus Therapeutics, Inc.
11.1.1 Amicus Therapeutics, Inc. Corporation Information
11.1.2 Amicus Therapeutics, Inc. Description and Business Overview
11.1.3 Amicus Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amicus Therapeutics, Inc. Glucosylceramidase Products Offered
11.1.5 Amicus Therapeutics, Inc. Related Developments
11.2 Bioorganic Research and Services S.A.
11.2.1 Bioorganic Research and Services S.A. Corporation Information
11.2.2 Bioorganic Research and Services S.A. Description and Business Overview
11.2.3 Bioorganic Research and Services S.A. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bioorganic Research and Services S.A. Glucosylceramidase Products Offered
11.2.5 Bioorganic Research and Services S.A. Related Developments
11.3 greenovation Biotech GmbH
11.3.1 greenovation Biotech GmbH Corporation Information
11.3.2 greenovation Biotech GmbH Description and Business Overview
11.3.3 greenovation Biotech GmbH Sales, Revenue and Gross Margin (2015-2020)
11.3.4 greenovation Biotech GmbH Glucosylceramidase Products Offered
11.3.5 greenovation Biotech GmbH Related Developments
11.4 JCR Pharmaceuticals Co., Ltd.
11.4.1 JCR Pharmaceuticals Co., Ltd. Corporation Information
11.4.2 JCR Pharmaceuticals Co., Ltd. Description and Business Overview
11.4.3 JCR Pharmaceuticals Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Products Offered
11.4.5 JCR Pharmaceuticals Co., Ltd. Related Developments
11.5 Pharming Group N.V.
11.5.1 Pharming Group N.V. Corporation Information
11.5.2 Pharming Group N.V. Description and Business Overview
11.5.3 Pharming Group N.V. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pharming Group N.V. Glucosylceramidase Products Offered
11.5.5 Pharming Group N.V. Related Developments
11.6 Protalix BioTherapeutics, Inc.
11.6.1 Protalix BioTherapeutics, Inc. Corporation Information
11.6.2 Protalix BioTherapeutics, Inc. Description and Business Overview
11.6.3 Protalix BioTherapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Protalix BioTherapeutics, Inc. Glucosylceramidase Products Offered
11.6.5 Protalix BioTherapeutics, Inc. Related Developments
11.7 Takeda
11.7.1 Takeda Corporation Information
11.7.2 Takeda Description and Business Overview
11.7.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Takeda Glucosylceramidase Products Offered
11.7.5 Takeda Related Developments
11.8 The International Biotechnology Center (IBC) Generium
11.8.1 The International Biotechnology Center (IBC) Generium Corporation Information
11.8.2 The International Biotechnology Center (IBC) Generium Description and Business Overview
11.8.3 The International Biotechnology Center (IBC) Generium Sales, Revenue and Gross Margin (2015-2020)
11.8.4 The International Biotechnology Center (IBC) Generium Glucosylceramidase Products Offered
11.8.5 The International Biotechnology Center (IBC) Generium Related Developments
11.1 Amicus Therapeutics, Inc.
11.1.1 Amicus Therapeutics, Inc. Corporation Information
11.1.2 Amicus Therapeutics, Inc. Description and Business Overview
11.1.3 Amicus Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amicus Therapeutics, Inc. Glucosylceramidase Products Offered
11.1.5 Amicus Therapeutics, Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Glucosylceramidase Market Estimates and Projections by Region
12.1.1 Global Glucosylceramidase Sales Forecast by Regions 2021-2026
12.1.2 Global Glucosylceramidase Revenue Forecast by Regions 2021-2026
12.2 North America Glucosylceramidase Market Size Forecast (2021-2026)
12.2.1 North America: Glucosylceramidase Sales Forecast (2021-2026)
12.2.2 North America: Glucosylceramidase Revenue Forecast (2021-2026)
12.2.3 North America: Glucosylceramidase Market Size Forecast by Country (2021-2026)
12.3 Europe Glucosylceramidase Market Size Forecast (2021-2026)
12.3.1 Europe: Glucosylceramidase Sales Forecast (2021-2026)
12.3.2 Europe: Glucosylceramidase Revenue Forecast (2021-2026)
12.3.3 Europe: Glucosylceramidase Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Glucosylceramidase Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Glucosylceramidase Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Glucosylceramidase Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Glucosylceramidase Market Size Forecast by Region (2021-2026)
12.5 Latin America Glucosylceramidase Market Size Forecast (2021-2026)
12.5.1 Latin America: Glucosylceramidase Sales Forecast (2021-2026)
12.5.2 Latin America: Glucosylceramidase Revenue Forecast (2021-2026)
12.5.3 Latin America: Glucosylceramidase Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Glucosylceramidase Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Glucosylceramidase Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Glucosylceramidase Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Glucosylceramidase Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Glucosylceramidase Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Glucosylceramidase Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Glucosylceramidase Market Segments
Table 2. Ranking of Global Top Glucosylceramidase Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Glucosylceramidase Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of AVRRD-02
Table 5. Major Manufacturers of LTI-291
Table 6. Major Manufacturers of NCGC-607
Table 7. Major Manufacturers of Pcgin
Table 8. Major Manufacturers of Others
Table 9. Global Glucosylceramidase Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Glucosylceramidase Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Glucosylceramidase Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Glucosylceramidase Sales Market Share by Regions (2015-2020)
Table 13. Global Glucosylceramidase Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Glucosylceramidase Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Glucosylceramidase Sales Share by Manufacturers (2015-2020)
Table 16. Global Glucosylceramidase Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Glucosylceramidase by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucosylceramidase as of 2019)
Table 18. Glucosylceramidase Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Glucosylceramidase Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Glucosylceramidase Price (2015-2020) (USD/Pcs)
Table 21. Glucosylceramidase Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Glucosylceramidase Product Type
Table 23. Date of International Manufacturers Enter into Glucosylceramidase Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Glucosylceramidase Sales by Type (2015-2020) (K Pcs)
Table 26. Global Glucosylceramidase Sales Share by Type (2015-2020)
Table 27. Global Glucosylceramidase Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Glucosylceramidase Revenue Share by Type (2015-2020)
Table 29. Glucosylceramidase Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Glucosylceramidase Sales by Application (2015-2020) (K Pcs)
Table 31. Global Glucosylceramidase Sales Share by Application (2015-2020)
Table 32. North America Glucosylceramidase Sales by Country (2015-2020) (K Pcs)
Table 33. North America Glucosylceramidase Sales Market Share by Country (2015-2020)
Table 34. North America Glucosylceramidase Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Glucosylceramidase Revenue Market Share by Country (2015-2020)
Table 36. North America Glucosylceramidase Sales by Type (2015-2020) (K Pcs)
Table 37. North America Glucosylceramidase Sales Market Share by Type (2015-2020)
Table 38. North America Glucosylceramidase Sales by Application (2015-2020) (K Pcs)
Table 39. North America Glucosylceramidase Sales Market Share by Application (2015-2020)
Table 40. Europe Glucosylceramidase Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Glucosylceramidase Sales Market Share by Country (2015-2020)
Table 42. Europe Glucosylceramidase Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Glucosylceramidase Revenue Market Share by Country (2015-2020)
Table 44. Europe Glucosylceramidase Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Glucosylceramidase Sales Market Share by Type (2015-2020)
Table 46. Europe Glucosylceramidase Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Glucosylceramidase Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Glucosylceramidase Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Glucosylceramidase Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Glucosylceramidase Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Glucosylceramidase Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Glucosylceramidase Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Glucosylceramidase Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Glucosylceramidase Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Glucosylceramidase Sales Market Share by Application (2015-2020)
Table 56. Latin America Glucosylceramidase Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Glucosylceramidase Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Glucosylceramidase Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Glucosylceramidase Revenue Market Share by Country (2015-2020)
Table 60. Latin America Glucosylceramidase Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Glucosylceramidase Sales Market Share by Type (2015-2020)
Table 62. Latin America Glucosylceramidase Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Glucosylceramidase Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Glucosylceramidase Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Glucosylceramidase Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Glucosylceramidase Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Glucosylceramidase Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Glucosylceramidase Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Glucosylceramidase Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Glucosylceramidase Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Glucosylceramidase Sales Market Share by Application (2015-2020)
Table 72. Amicus Therapeutics, Inc. Corporation Information
Table 73. Amicus Therapeutics, Inc. Description and Major Businesses
Table 74. Amicus Therapeutics, Inc. Glucosylceramidase Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Amicus Therapeutics, Inc. Product
Table 76. Amicus Therapeutics, Inc. Recent Development
Table 77. Bioorganic Research and Services S.A. Corporation Information
Table 78. Bioorganic Research and Services S.A. Description and Major Businesses
Table 79. Bioorganic Research and Services S.A. Glucosylceramidase Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Bioorganic Research and Services S.A. Product
Table 81. Bioorganic Research and Services S.A. Recent Development
Table 82. greenovation Biotech GmbH Corporation Information
Table 83. greenovation Biotech GmbH Description and Major Businesses
Table 84. greenovation Biotech GmbH Glucosylceramidase Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. greenovation Biotech GmbH Product
Table 86. greenovation Biotech GmbH Recent Development
Table 87. JCR Pharmaceuticals Co., Ltd. Corporation Information
Table 88. JCR Pharmaceuticals Co., Ltd. Description and Major Businesses
Table 89. JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. JCR Pharmaceuticals Co., Ltd. Product
Table 91. JCR Pharmaceuticals Co., Ltd. Recent Development
Table 92. Pharming Group N.V. Corporation Information
Table 93. Pharming Group N.V. Description and Major Businesses
Table 94. Pharming Group N.V. Glucosylceramidase Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Pharming Group N.V. Product
Table 96. Pharming Group N.V. Recent Development
Table 97. Protalix BioTherapeutics, Inc. Corporation Information
Table 98. Protalix BioTherapeutics, Inc. Description and Major Businesses
Table 99. Protalix BioTherapeutics, Inc. Glucosylceramidase Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Protalix BioTherapeutics, Inc. Product
Table 101. Protalix BioTherapeutics, Inc. Recent Development
Table 102. Takeda Corporation Information
Table 103. Takeda Description and Major Businesses
Table 104. Takeda Glucosylceramidase Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Takeda Product
Table 106. Takeda Recent Development
Table 107. The International Biotechnology Center (IBC) Generium Corporation Information
Table 108. The International Biotechnology Center (IBC) Generium Description and Major Businesses
Table 109. The International Biotechnology Center (IBC) Generium Glucosylceramidase Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. The International Biotechnology Center (IBC) Generium Product
Table 111. The International Biotechnology Center (IBC) Generium Recent Development
Table 112. Global Glucosylceramidase Sales Forecast by Regions (2021-2026) (K Pcs)
Table 113. Global Glucosylceramidase Sales Market Share Forecast by Regions (2021-2026)
Table 114. Global Glucosylceramidase Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 115. Global Glucosylceramidase Revenue Market Share Forecast by Regions (2021-2026)
Table 116. North America: Glucosylceramidase Sales Forecast by Country (2021-2026) (K Pcs)
Table 117. North America: Glucosylceramidase Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Europe: Glucosylceramidase Sales Forecast by Country (2021-2026) (K Pcs)
Table 119. Europe: Glucosylceramidase Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Asia Pacific: Glucosylceramidase Sales Forecast by Region (2021-2026) (K Pcs)
Table 121. Asia Pacific: Glucosylceramidase Revenue Forecast by Region (2021-2026) (US$ Million)
Table 122. Latin America: Glucosylceramidase Sales Forecast by Country (2021-2026) (K Pcs)
Table 123. Latin America: Glucosylceramidase Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Middle East and Africa: Glucosylceramidase Sales Forecast by Country (2021-2026) (K Pcs)
Table 125. Middle East and Africa: Glucosylceramidase Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 127. Key Challenges
Table 128. Market Risks
Table 129. Main Points Interviewed from Key Glucosylceramidase Players
Table 130. Glucosylceramidase Customers List
Table 131. Glucosylceramidase Distributors List
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Glucosylceramidase Product Picture
Figure 2. Global Glucosylceramidase Sales Market Share by Type in 2020 & 2026
Figure 3. AVRRD-02 Product Picture
Figure 4. LTI-291 Product Picture
Figure 5. NCGC-607 Product Picture
Figure 6. Pcgin Product Picture
Figure 7. Others Product Picture
Figure 8. Global Glucosylceramidase Sales Market Share by Application in 2020 & 2026
Figure 9. Genetic Disorders
Figure 10. Gaucher Disease
Figure 11. Parkinson's Disease
Figure 12. Others
Figure 13. Glucosylceramidase Report Years Considered
Figure 14. Global Glucosylceramidase Market Size 2015-2026 (US$ Million)
Figure 15. Global Glucosylceramidase Sales 2015-2026 (K Pcs)
Figure 16. Global Glucosylceramidase Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Glucosylceramidase Sales Market Share by Region (2015-2020)
Figure 18. Global Glucosylceramidase Sales Market Share by Region in 2019
Figure 19. Global Glucosylceramidase Revenue Market Share by Region (2015-2020)
Figure 20. Global Glucosylceramidase Revenue Market Share by Region in 2019
Figure 21. Global Glucosylceramidase Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Glucosylceramidase Revenue in 2019
Figure 23. Glucosylceramidase Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Glucosylceramidase Sales Market Share by Type (2015-2020)
Figure 25. Global Glucosylceramidase Sales Market Share by Type in 2019
Figure 26. Global Glucosylceramidase Revenue Market Share by Type (2015-2020)
Figure 27. Global Glucosylceramidase Revenue Market Share by Type in 2019
Figure 28. Global Glucosylceramidase Market Share by Price Range (2015-2020)
Figure 29. Global Glucosylceramidase Sales Market Share by Application (2015-2020)
Figure 30. Global Glucosylceramidase Sales Market Share by Application in 2019
Figure 31. Global Glucosylceramidase Revenue Market Share by Application (2015-2020)
Figure 32. Global Glucosylceramidase Revenue Market Share by Application in 2019
Figure 33. North America Glucosylceramidase Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Glucosylceramidase Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Glucosylceramidase Sales Market Share by Country in 2019
Figure 36. North America Glucosylceramidase Revenue Market Share by Country in 2019
Figure 37. U.S. Glucosylceramidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Glucosylceramidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Glucosylceramidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Glucosylceramidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Glucosylceramidase Market Share by Type in 2019
Figure 42. North America Glucosylceramidase Market Share by Application in 2019
Figure 43. Europe Glucosylceramidase Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Glucosylceramidase Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Glucosylceramidase Sales Market Share by Country in 2019
Figure 46. Europe Glucosylceramidase Revenue Market Share by Country in 2019
Figure 47. Germany Glucosylceramidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Glucosylceramidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Glucosylceramidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Glucosylceramidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Glucosylceramidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Glucosylceramidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Glucosylceramidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Glucosylceramidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Glucosylceramidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Glucosylceramidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Glucosylceramidase Market Share by Type in 2019
Figure 58. Europe Glucosylceramidase Market Share by Application in 2019
Figure 59. Asia Pacific Glucosylceramidase Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Glucosylceramidase Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Glucosylceramidase Sales Market Share by Region in 2019
Figure 62. Asia Pacific Glucosylceramidase Revenue Market Share by Region in 2019
Figure 63. China Glucosylceramidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Glucosylceramidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Glucosylceramidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Glucosylceramidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Glucosylceramidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Glucosylceramidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Glucosylceramidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Glucosylceramidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Glucosylceramidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Glucosylceramidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Glucosylceramidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Glucosylceramidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Glucosylceramidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Glucosylceramidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Glucosylceramidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Glucosylceramidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Glucosylceramidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Glucosylceramidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Glucosylceramidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Glucosylceramidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Glucosylceramidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Glucosylceramidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Glucosylceramidase Market Share by Type in 2019
Figure 86. Asia Pacific Glucosylceramidase Market Share by Application in 2019
Figure 87. Latin America Glucosylceramidase Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Glucosylceramidase Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Glucosylceramidase Sales Market Share by Country in 2019
Figure 90. Latin America Glucosylceramidase Revenue Market Share by Country in 2019
Figure 91. Mexico Glucosylceramidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Glucosylceramidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Glucosylceramidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Glucosylceramidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Glucosylceramidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Glucosylceramidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Glucosylceramidase Market Share by Type in 2019
Figure 98. Latin America Glucosylceramidase Market Share by Application in 2019
Figure 99. Middle East and Africa Glucosylceramidase Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Glucosylceramidase Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Glucosylceramidase Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Glucosylceramidase Revenue Market Share by Country in 2019
Figure 103. Turkey Glucosylceramidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Glucosylceramidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Glucosylceramidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Glucosylceramidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Glucosylceramidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Glucosylceramidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Glucosylceramidase Market Share by Type in 2019
Figure 110. Middle East and Africa Glucosylceramidase Market Share by Application in 2019
Figure 111. North America Glucosylceramidase Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Glucosylceramidase Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Glucosylceramidase Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Glucosylceramidase Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Glucosylceramidase Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Glucosylceramidase Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Glucosylceramidase Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Glucosylceramidase Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Glucosylceramidase Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Glucosylceramidase Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
ゴーシェ病治療の世界市場（～2026年） Market Analysis and Insights: Global Gaucher Disease Treatment Market The global Gaucher Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Gaucher Disease Treatment Scope and Market Size Gaucher Disease…- パーキンソン病の世界市場（～2026年） Market Analysis and Insights: Global Parkinson's Disease Market The global Parkinson's Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Parkinson's Disease Scope and Market Size Parkinson's Disease market is seg…
- パーキンソン病治療の世界市場（～2026年） Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system. There is no cure for Parkinson's disease, with treatment directed at improving symptoms. Initial treatment is typically with the antiparkinson medication levodopa (L-DOPA…
- ゴーシェ病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Gaucher Disease Drugs Market The global Gaucher Disease Drugs market size is projected to reach US$ 1330 million by 2026, from US$ 1321 million in 2020, at a CAGR of 0.6%% during 2021-2026. Global Gaucher Disease Drugs Scope and Market Size Gaucher Disease Drugs …
- 遺伝病診断の世界市場（～2026年） Test the genetic disease. For example, color blindness, Down'ssyndrome, cystic fibrosis,etc Rising incidences of genetic disorders that give rise to wide variety of independent diagnostic procedures globally is predominantly driving the growth of the global genetic disorder diagnostic market. Additi…